I AM BIO

Follow I AM BIO
Share on
Copy link to clipboard

Powerful stories of biotechnology breakthroughs, the people they help, the global problems they solve, and the politicians with the power to mess it all up. Hosted by former Congressman Jim Greenwood.

Biotechnology Innovation Organization


    • Nov 19, 2024 LATEST EPISODE
    • monthly NEW EPISODES
    • 29m AVG DURATION
    • 131 EPISODES

    4.9 from 82 ratings Listeners of I AM BIO that love the show mention: tree, science.



    Search for episodes from I AM BIO with a specific topic:

    Latest episodes from I AM BIO

    The Faceless Middleman Between You and Your Doctor

    Play Episode Listen Later Nov 19, 2024 26:43


    A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk. Policies like step therapy and prior authorization are forcing individuals into treatments not recommended by their doctors—often with devastating consequences. In this episode, we hear from a patient who endured months of suffering due to her insurer's 'fail-first' requirements. We also talk with a doctor navigating this impossible system and a biotech leader fighting to ensure innovative treatments reach the patients who need them most. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)

    Play Episode Listen Later Nov 5, 2024 28:02


    The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins.In this episode we talk with three experts about how this animal's unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    How Love Combined with Science Leads to Hope for Rare Disease

    Play Episode Listen Later Oct 22, 2024 27:05


    There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers. In this episode, we talk with one of those families and the biotech company offering them new hope. We also talk with an expert on policy that has jump-started R&D for rare diseases.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    How Will We Secure our Food Future?

    Play Episode Listen Later Oct 8, 2024 26:15


    As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent. Climate change is further straining food systems, impacting water availability, crop yields, and livestock health. In this episode, two experts discuss innovative biotech solutions aimed at addressing these pressing issues, offering hope for a sustainable path forward in feeding the world.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Biotechnology is a National Security Asset

    Play Episode Listen Later Sep 24, 2024 27:14


    Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    A Doctor Fights to Save His Own Life: The David Fajgenbaum Story.

    Play Episode Listen Later Sep 10, 2024 21:33


    David Fajgenbaum was in his third year of medical school when he was diagnosed with a rare and life-threatening disease that began shutting down his organs, bringing him perilously close to death. Although he survived the initial episode, he faced four additional relapses, each pushing him to the brink of death. In this episode, we speak with David about his relentless journey to discover the treatment that ultimately put his disease into remission. We also explore how his personal battle inspired the creation of a groundbreaking approach to help others suffering from rare diseases.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    What We Know About the Microbiome (REDUX)

    Play Episode Listen Later Aug 6, 2024 27:25


    The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don't. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.

    Is CRISPR the New Sickle Cell Savior? (REDUX)

    Play Episode Listen Later Jul 24, 2024 24:39


    2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients. 

    Listener takeover: Your Biotech Questions Answered

    Play Episode Listen Later May 7, 2024 21:29


    YOU asked, and we answered. In this episode, we had our experts on standby to answer questions from you, our listeners. We discuss topics ranging from the safety of genetically modified foods (GMOs), to the new era of personalized medicine, feeding the world by 2050, and even what makes start-up companies attractive to investors.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Editing Cells Within the Body—a New CRISPR Frontier

    Play Episode Listen Later Apr 23, 2024 21:21


    With its potential to expand the horizons of what's possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near future. In this episode we talk with two companies working together on the next generation of CRISPR: editing cells within the body.  We discuss the progress and the challenge in making this breakthrough a reality. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Biotech is Climate Tech

    Play Episode Listen Later Apr 9, 2024 21:27


    Biotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Biotech for our Pets

    Play Episode Listen Later Mar 26, 2024 28:21


    More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    What We Know About the Microbiome

    Play Episode Listen Later Mar 12, 2024 27:25


    The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don't. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Is CRISPR the New Sickle Cell Savior?

    Play Episode Listen Later Feb 27, 2024 24:39


    2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    “On My Own”—Desperate to Stop a Resistant Bacterial Infection (REDUX)

    Play Episode Listen Later Feb 6, 2024 27:42


    Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it's normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to mad scientist, to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    The Synbio Revolution is Here (REDUX)

    Play Episode Listen Later Jan 23, 2024 26:14


    Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we've entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with three synbio experts about how this convergence of genetic engineering, computer science and other scientific disciplines is making our world more sustainable. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    How Biotechs Survive the Valley of Death (REDUX)

    Play Episode Listen Later Jan 10, 2024 25:05


    For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it's like to struggle and survive in this rough-and-tumble industry.  Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    Biotech Women Striking at the Glass Ceiling (REDUX)

    Play Episode Listen Later Dec 26, 2023 24:38


    The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women's leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women's success in corporate leadership and mentor the next generation of women executives.  Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    We Need Bees. Bees Need Biotech. (REDUX)

    Play Episode Listen Later Dec 12, 2023 26:47


    Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That's why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming.In this episode we talk with an expert on bees and other pollinators about how bees are doing and why it's important to save them. We also talk with two biotech leaders whose companies are working to improve bee health through development of innovative treatments for some of the worst threats faced by bees.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)

    Play Episode Listen Later Nov 28, 2023 28:02


    The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins.In this episode we talk with three experts about how this animal's unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

    “On My Own”—Desperate to Stop a Resistant Bacterial Infection

    Play Episode Listen Later Nov 14, 2023 27:42


    Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it's normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to "mad scientist" to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/Click HERE to watch the documentary-style film Race Against Resistance presented by the AMR Action Fund and funding support from Pfizer Shionogi and MSD.

    The Synbio Revolution is Here

    Play Episode Listen Later Oct 31, 2023 26:14


    Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we've entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with three synbio experts about how this convergence of genetic engineering, computer science and other scientific disciplines is making our world more sustainable. 

    How Biotechs Survive the Valley of Death

    Play Episode Listen Later Oct 17, 2023 25:05


    Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it's like to struggle and survive in this rough-and-tumble industry. 

    Biotech Women Striking at the Glass Ceiling

    Play Episode Listen Later Oct 3, 2023 24:38


    Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women's leadership matters and the barriers that remain to breaking the glass ceiling. They also tell us about a new networking initiative—the biotech sisterhood—to catalyze women's success in corporate leadership and mentor the next generation of women executives.     

    We Need Bees. Bees Need Biotech.

    Play Episode Listen Later Sep 19, 2023 26:47


    Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That's why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming.In this episode we talk with an expert on bees and other pollinators about how bees are doing and why it's important to save them. We also talk with two biotech leaders whose companies are working to improve bee health through development of innovative treatments for some of the worst threats faced by bees.

    The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab?

    Play Episode Listen Later Sep 5, 2023 28:02


    Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins.In this episode we talk with three experts about how this animal's unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.

    Stand Up for Science—The Fight Against Misinformation (Redux)

    Play Episode Listen Later Aug 15, 2023 25:34


    Wading through the torrent of information available online is challenging for everyone. It can be hard to know what and whom to believe. We talk with the FDA Commissioner and other leaders on the frontlines of health and science about how to be more aware of false and misleading information, and its risks to our wellbeing and future innovation. And we discuss ways to stand up for science and stop the spread of misinformation. 

    Is Space the Next Frontier for Biotech? (Redux)

    Play Episode Listen Later Aug 1, 2023 27:18


    The International Space Station has been orbiting in lower earth since 1998 and has been continually inhabited since November 2000. The ISS was originally conceived as a staging base for future missions into deep space. As it turns out, lower earth orbit is an ideal setting for scientific research, from physics and meteorology to astronomy and the life sciences. In this episode we talk with three scientists whose projects are using lower earth orbit to deepen our knowledge of biotechnology and its benefits for mankind.

    The New Age of CRISPR (Redux)

    Play Episode Listen Later Jul 18, 2023 27:40


    CRISPR has emerged as a powerful tool for altering DNA sequences with incredible precision, opening up new avenues of research into the treatment of disease. In this episode, we explore the science behind CRISPR, as well as its potential. From curing genetic disorders to creating new crop varieties, the possibilities seem endless. Our four guests today are scientists working to push these gene editing tools to the next frontier.

    Accelerating Hope: The Pathway for Cures (Redux)

    Play Episode Listen Later Jul 4, 2023 23:00


    When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threatening conditions. In this episode we talk with the father of children with a rare disease, a company CEO working to treat rare diseases and two policy experts on Accelerated Approval.

    Why AI and Biotech are BFFs (Redux)

    Play Episode Listen Later Jun 20, 2023 21:49


    The convergence of Artificial Intelligence (AI) and biotechnology has emerged as one of the most exciting and transformative areas of science. Researchers are developing new tools and technology that could bring about breakthroughs to revolutionize the fields of medicine and health care.  In this episode, we talk with scientists who are using AI to unlock new possibilities in the search for novel drugs, cures, and treatments.

    Cracking the Code on Pain Relief (Redux)

    Play Episode Listen Later Jun 6, 2023 26:02


    Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment in new pain and addiction treatments is falling short of what is needed, according to a new BIO report, which shows a 44% decrease in clinical drug programs for pain over the past five years. Our guests on this episode talk about the challenges of living with and treating pain, as well as research and development on new, non-addictive and safer pain therapies. 

    Why are Katie Couric and 15K People Headed to Boston?

    Play Episode Listen Later May 23, 2023 16:09


    During the last several decades Boston has become a biotech Mecca, with its Kendall Square attracting more than 120 biotech companies, both large and small. It is called the most innovative square mile on the planet.  This June BIO will bring over 15,000 biotech leaders to Boston for its 2023 BIO International Convention. Speakers including award-winning journalist and health advocate, Katie Couric, will talk about how they will “Stand up for Science”—the Convention's theme. MassBIO CEO, Kendalle Burlin O'Connell joins host, Rachel King in a wide-ranging discussion about how Boston became the largest biotech hub in the world.

    Stand Up for Science—The Fight Against Misinformation

    Play Episode Listen Later May 9, 2023 25:34


    Wading through the torrent of information available online is challenging for everyone. It can be hard to know what and whom to believe. We talk with the FDA Commissioner and other leaders on the frontlines of health and science about how to be more aware of false and misleading information, and its risks to our wellbeing and future innovation. And we discuss ways to stand up for science and stop the spread of misinformation. 

    Is Space the Next Frontier for Biotech?

    Play Episode Listen Later Apr 25, 2023 27:18


    The International Space Station has been orbiting in lower earth since 1998 and has been continually inhabited since November 2000. The ISS was originally conceived as a staging base for future missions into deep space. As it turns out, lower earth orbit is an ideal setting for scientific research, from physics and meteorology to astronomy and the life sciences. In this episode we talk with three scientists whose projects are using lower earth orbit to deepen our knowledge of biotechnology and its benefits for mankind.

    The New Age of CRISPR

    Play Episode Listen Later Apr 11, 2023 27:40


    CRISPR has emerged as a powerful tool for altering DNA sequences with incredible precision, opening up new avenues of research into the treatment of disease. In this episode, we explore the science behind CRISPR, as well as its potential. From curing genetic disorders to creating new crop varieties, the possibilities seem endless. Our four guests today are scientists working to push these gene editing tools to the next frontier.

    Accelerating Hope: The Pathway for Cures

    Play Episode Listen Later Mar 28, 2023 23:00


    When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threatening conditions. In this episode we talk with the father of children with a rare disease, a company CEO working to treat rare diseases and two policy experts on Accelerated Approval.

    Why AI and Biotech are BFFs

    Play Episode Listen Later Mar 14, 2023 21:49


    The convergence of Artificial Intelligence (AI) and biotechnology has emerged as one of the most exciting and transformative areas of science. Researchers are developing new tools and technology that could bring about breakthroughs to revolutionize the fields of medicine and health care.  In this episode, we talk with scientists who are using AI to unlock new possibilities in the search for novel drugs, cures, and treatments.

    Cracking the Code on Pain Relief

    Play Episode Listen Later Feb 28, 2023 26:02


    Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment in new pain and addiction treatments is falling short of what is needed, according to a new BIO report, which shows a 44% decrease in clinical drug programs for pain over the past five years. Our guests on this episode talk about the challenges of living with and treating pain, as well as research and development on new, non-addictive and safer pain therapies. 

    Psychedelics – Not Just For Hippies Anymore (Redux)

    Play Episode Listen Later Feb 14, 2023 20:56


    Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health. Guests:Dr. Frank Wiegand, Chief Medical Officer, Beckley PsytechKurt Rasmussen, Ph.D., Chief Scientific Officer, Delix TherapeuticsClara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures

    Green Fuels Have Taken Off (Redux)

    Play Episode Listen Later Jan 31, 2023 19:59


    Last December, a United Airlines' flight from Chicago to Washington DC was the first ever passenger flight powered with 100% sustainable aviation fuel. The achievement demonstrated the potential for the aviation sector to reduce its carbon footprint. Our guests in this episode each played a key role in in helping the airline reach this exciting milestone.

    Antimicrobial Resistance: The Silent Pandemic (Redux)

    Play Episode Listen Later Jan 10, 2023 26:53


    We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how the dwindling supply of new antibiotics is fueling this silent pandemic, and why we need a continued pipeline of new antibiotics to avoid this crisis.Guests:Ankit Mahadevia, Spero TherapeuticsHenry  Skinner, AMR Action FundMary Dwight, Cystic Fibrosis Foundation 

    New Season of I am BIO; plus Hope for Alzheimer's (Redux)

    Play Episode Listen Later Dec 20, 2022 22:47


    I am BIO will begin a new season of exciting topics on Feb 28. During our hiatus, we are bringing back some of our most popular episodes beginning with “Hope for Alzheimer's.”Alzheimer's disease is a heartbreaking diagnosis and tragically there is no cure. But every day, researchers, scientists and the medical community are working to change that. In this episode, we speak with three guests who are fighting to bend the trajectory of Alzheimer's disease and, in doing so, offering hope for the millions suffering from this devastating illness.

    Let's Get Uncomfortable: Talking About Women's Health

    Play Episode Listen Later Nov 29, 2022 24:47


    Talking about women's health has been a taboo subject for some time, contributing to a lack of innovation in the sector. Still today, many are uncomfortable discussing the topic. Consequently, only 2% of medical products in the pipeline are for women's health and only 2% of all venture capital dollars go into developing these products. In this episode, we talk with two women in biotech who are trying to change that narrative and infuse more investment in innovations that meet the needs of half the population.Sabrina Martucci Johnson, CEODaré BioscienceElizabeth Baily, Managing DirectorRH Capital 

    Microbes, Bioplastics … and Art: Solutions to Plastic Pollution

    Play Episode Listen Later Nov 15, 2022 24:19


    Plastic is polluting our waterways and oceans, but biotechnology may deliver solutions. Plant-based bioplastics that can break down in months are one solution. Another is mighty microbes bioengineered to speed up consumption of plastic. This episode spotlights scientists, companies and even a filmmaker and artist who are working in different ways to tackle the growing problem of plastic waste. Guests:Scott Tuten, Chief Marketing and Sustainability Officer, Danimer ScientificAndrew Held, Vice President of Engineering & Business, VirentDr. Tae Seok Moon, Associate Professor of Energy, Environmental & Chemical Engineering, Washington University in St. Louis, Founder and head of the Scientific Advisory Board, Moonshot BioBen Lear, Independent Film Producer/Director

    Psychedelics – Not Just For Hippies Anymore

    Play Episode Listen Later Nov 1, 2022 20:56


    Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health. Guests:Dr. Frank Wiegand, Chief Medical Officer, Beckley PsytechKurt Rasmussen, Ph.D., Chief Scientific Officer, Delix TherapeuticsClara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures

    The Surprising Role of Patient Advocates in Drug Development

    Play Episode Listen Later Oct 18, 2022 20:55


    Patient Advocates do more than raise money—they are active participants in the drug development process. While the ALS Ice Bucket Challenge garnered global attention, lesser-known patient advocates also flex their expertise to drive new treatments and cures.  In this episode, we talk with two moms, one who is a patient herself, about their work as partners in research and development, helping bring treatments for two rare diseases to the market. Susan Ruediger, Founder and Chief Mission Officer, CMT Research Foundation  Nasha Fitter, CEO, FOXG1 Research Foundation   

    Lessons from Monkeypox: Are We Prepared for the Next Pandemic?

    Play Episode Listen Later Oct 4, 2022 17:51


    Monkeypox hit our shores in May of this year. How did our public health agencies and infrastructure perform? What went right, what went wrong, and what needs to improve? We talked with three experts in public health and biodefense about the threats on their radar screens and how the U.S. can better prepare for the next inevitable outbreak or pandemic.Guests:Dr. Asha George, Bipartisan Commission on BiodefenseDr. Lynn Goldman, Milken Institute School of Public Health at the George Washington UniversityDr. John Redd, Medical Countermeasures Coalition 

    Data Storage Crisis: DNA to the Rescue

    Play Episode Listen Later Sep 20, 2022 25:10


    You might be surprised to learn that data storage currently requires huge amounts of land and energy, and we're running out of both. In this episode, we speak with a small group of researchers who are working to revolutionize the way we store the massive amounts of data we produce every day. Their solution: use DNA.Speakers:Emily Leproust, Twist BioscienceJeff Nivala, University of WashingtonKyle Tomek, DNAli Technologies

    Investment Climate For Biotech

    Play Episode Listen Later May 31, 2022 25:50


    Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.Speakers:Bill Newell, Sutro BiopharmaDr. Lisa Drakeman, Biotech EntrepreneurSougato Das, PRISM.science 

    Drug Prices: A Dysfunctional Market Limits Patient Access

    Play Episode Listen Later May 17, 2022 25:55


    A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn't'—and the consequences of a dysfunctional pricing system.Guests:Dan Durham, Senior Health Policy Advisor, Biotechnology Innovation OrganizationAnna Hyde, Vice President, Advocacy and Access, Arthritis FoundationDr. Vinay Rathi, Resident Physician, Otolaryngology, Massachusetts Eye and Ear and Mass General Brigham

    Claim I AM BIO

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel